ST segment elevation differs depending on the method of measurement

Academic Emergency Medicine

Volumn 13, Issue 4, 2006, Pages 406-412

  Smith, Stephen W ^a,b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acute myocardial infarction; Clinical trial; Electrocardiography; Percutaneous coronary intervention; Reperfusion therapy; ST elevation

Indexed keywords

ACUTE HEART INFARCTION; ARTERY OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION; REVIEW; ST SEGMENT ELEVATION; TECHNIQUE;

EID: 33645325930     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2005.10.019     Document Type: Article

References (30)

1. H.R. Andersen, T.T. Nielsen, and K. Rasmussen DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
2. Mitsubishi Pharma Corp. A phase IIa, randomized, double-blind, placebo-controlled clinical trial to examine the safety and efficacy of intravenous MCC-135 as an adjunct to standard therapy with primary PCI in patients diagnosed as having an ST elevation acute myocardial infarction. Available at: http://www.clinicaltrials.gov/ct/show/NCT00078013. Accessed Oct 28, 2005.
3. R.S. Forest, F.S. Shofer, K.L. Sease, and J.E. Hollander Assessment of the standardized reporting guidelines ECG classification system: the presenting ECG predicts 30-day outcomes Ann Emerg Med 44 2004 206 212
4. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J Am Coll Cardiol 44 2004 671 719
5. GISSI. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study Lancet 2 1987 871 874
6. GISSI-2 (Gruppo Italiano Per Lo Studio Della Sopravivenza Nell'Infarto Miocardio). GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction Lancet 336 1990 65 71
7. GUSTO-I Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction N Engl J Med 329 1993 673 682
8. GUSTO III. A comparison of reteplase with alteplase for acute myocardial infarction N Engl J Med 337 1997 1118 1123
9. V. GUSTO, A.M. Lincoff, R.M. Califf, and F. Van de Werf Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional therapy for acute myocardial infarction. GUSTO-V randomized trial JAMA 288 2002 2130 2135
10. H.S. Bush, J.J. Ferguson, P. Angelini, and J.T. Willerson Twelve-lead electrocardiographic evaluation of ischemia during percutaneous transluminal coronary angioplasty and its correlation with acute reocclusion Am Heart J 121 1991 1591 1599
11. J.L. Willems, R.J. Willems, G.M. Willems, A.E. Arno, F. Van de Werf, and M. Verstraete Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction Circulation 82 1990 1147 1158
12. A. Tamura, Y. Mikuriya, H. Kataoka, K. Nagase, and M. Nasu Emergent coronary angiographic findings of patients with ST depression in the inferior or lateral leads, or both, during anterior wall acute myocardial infarction Am J Cardiol 76 1995 516 517
13. M. Verstraete, R. Bernard, and M. Bory Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator Lancet 1 1985 842 847
14. G. Koren, A.T. Weiss, and Y. Hasin Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase N Engl J Med 313 1985 1384 1389
15. M. Cohen, H. Blanke, K.R. Karsh, J. Holt, and P. Rentrop Implications of precordial ST segment depression during acute inferior myocardial infarction: arteriographic and ventriculographic correlations during the acute phase Br Heart J 52 1984 497 501
16. S.N. Willich, P.H. Stone, and J.E. Muller High-risk subgroups of patients with non-Q wave myocardial infarction based on direction and severity of ST segment deviation Am Heart J 114 1987 1110 1119
17. S.D. Carley, R. Gamon, P.A. Driscoll, G. Brown, and P. Wallman What's the point of ST elevation? Emerg Med J 19 2002 126 128
18. M. Gwechenberger, W. Schreiber, and H. Kittler Prediction of early complications in patients with acute myocardial infarction by calculation of the ST score Ann Emerg Med 30 1997 563 570
19. H.R. Aldrich, N.B. Wagner, and J. Boswick Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts Am J Cardiol 61 1988 749 753
20. F.W. Bar, F. Vermeer, and C. de Zwaan Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction Am J Cardiol 59 1987 6 13
21. F. Van de Werf, and A.E. Arnold Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction BMJ 297 1988 1374 1379
22. P.G. Steg, E. Bonnefoy, and S. Chabaud Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial Circulation 108 2003 2851 2856
23. L. Wallentin, P. Goldstein, and P.W. Armstrong Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142
24. A. Kastrati, J. Mehilli, and K. Schlotterbeck Early administration of reteplase plus abciximab vs. abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial JAMA 291 2004 947 954
25. GISSI (Gruppo Italiano Per Lo Studio Della Sopravivenza Nell'Infarto Miocardio). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 401
26. Investigators GUSTO An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
27. A. Schomig, J. Mehilli, and D. Antoniucci Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial JAMA 293 2005 2865 2872
28. TargeGen. Safety of TG100-115 for heart attack treated with angioplasty. Available at: http://www.clinicaltrials.gov/ct/show/NCT00103350?order=1 2005. Accessed Oct 28, 2005.
29. The West Study. Which therapy for acute heart attacks? (The WEST Study). Available at: http://www.clinicaltrials.gov/ct/show/NCT00121446?order=2 2005. Accessed Oct 28, 2005.
30. Aventis. Enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment thrombolysis in myocardial infarction - study 25 (ExTRACT-TIMI25). Available at: http://www.clinicaltrials.gov/ct/show/ NCT00077792?order=9 2005. Accessed Oct 28, 2005.